Conference Description

October 8, 2005
Westin Diplomat Resort & Spa
355 South Ocean Drive
Hollywood, Florida
(888) 627-7218

Tell a friend about this conference
Download the brochure for this conference
See how attendees evaluated this conference

CME Credits 7.25*

Nonrefundable registration fee: $0.

Target Audience: Endocrinologists

Learning Objectives:
The intimate setting of the conference will maximize learning and discussion and will enable endocrinologists to learn first hand from thought leaders in their field. Among the proposed objectives will be:

1. review the incretins and endocannaboid system and their role in the pathophysiology and therapy of the metabolic syndrome and diabetes mellitus
2. review the role of the PPAR and the renin-angiotensin-aldosterone systems (RAAS) in preventing diabetes, diabetes complications and endothelial dysfunction
3. discuss the current status of inhaled insulin, insulin analogues and other delivery systems
4. describe the controversies surrounding sub clinical thyroid disease and review both pre and post operative US guided FNA and tissue markers in thyroid cancer surveillance

Agenda:

8:00 - 8:10		Welcome and Introduction Paul Jellinger, MD, MACE
		Diabetes and Cardiovascular Disease
8:10 - 8:50		The Role of Incretin Mimetics in the Treatment of Type 2 Diabetes Alain Baron, MD
8:50 - 9:30		Endocannabinoid Receptor Antagonists: Advances in Therapy for the Metaboloic Syndrome and Obesity Julio Rosenstock, MD
9:30 - 9:45		Q & A
9:45 - 10:10		Exhibits and Break
10:10 - 10:50		Diabetes and the Renin-Angiotensin-Aldosterone System: Preventing Diabetes and its Complications Andrew Selwyn, MD
10:50 - 11:00		Q & A
11:00 - 11:40		PPAR Agonists and Cardiovascular Disease: Current Concepts Willa Hsueh, MD
11:40 - 12:20		Diabetic Peripheral Neuropathy 2005: The Forgotten Complication Mike Pfeiffer, MD, MS, CDE, FACE
12:20 - 12:35		Q & A
12:35 - 1:35		Lunch -Special Presentation A Primer on Bone Density Interpretation Steve Petak, MD, FACE
1:35 - 2:15		Emerging Treatments for the Management of Type 2 Diabetes and the Metabolic Syndrome Harold Lebovitz, MD, FACE
2:15 - 2:25		Q & A
		Thyroid Disease
2:25 - 3:05		Subclinical Thyroid Disease: A Clinical Perspective Gilbert Daniels, MD, FACE
3:05 - 3:15		Q & A
3:15 - 3:35		Exhibits and Break
3:35 - 4:15		Ultrasound for the Surveillance of Thyroid Cancer H. Jack Baskin, MD, MACE
4:15 - 4:25		Q & A
		Pituitary
4:25 - 5:05		Pituitary Disorders: A Clinical Update Mark E. Molitch, MD
5:05 - 5:15		Q & A and Closing Remarks

Faculty:
Alain Baron, MD
Senior Vice President, Research
Amylin Pharmaceuticals

H. Jack Baskin, MD, MACE
Past President of the American Association of Clinical Endocrinologists
Master and Past President of the American College of Endocrinology
Director of the Florida Thyroid and Endocrine Clinic in Orlando

Gilbert Daniels, MD, FACE
Associate Professor of Medicine at Harvard Medical School and
Co-Director of the
Thyroid Clinic and
Physician at the Massachusetts General Hospital

Willa Hseuh, MD
Professor of Medicine Chief, Division of
Endocrinology, Diabetes and Hypertension
UCLA School of Medicine, Los Angeles

Harold Lebovitz, MD, FACE
Professor of Medicine at the Division of
Endocrinology and Metabolosim/Diabetes
at the State University of New York
Health Sciences Center at Brooklyn

Mark E. Molitch, MD
Professor of Medicine and a Member of the
Division of Endocrinology, Metabolism, and Molecular Medicine
at Northwestern University Feinberg School of Medicine, Chicago

Steven Petak, MD, FACE
Director of the Osteoporosis Center and Bone Densitometry Unit
at the Texas Institute for Reproductive Medicine and Endocrinology
Clinical Assistant Professor at the
Uiversity of Texas Medical School at Houston

Michael Pfeifer, MD, MS, CDE, FACE
Senior Clinical Director, Clinical Research and Medical Affairs – Diabetes
Novo Nordisk Inc.

Julio Rosenstock, MD
Director of Dallas Diabetes and Endocrine Center
Clincal Professor of Medicine at the
University of Texas Southwestern Medical Center at Dallas

Andrew Selwyn, MD
Professor of Medicine, Harvard Medical School
Director of the Cardiac Catherization Laboratory, Faulkner Hospital
Senior Physician, Brigham and Women's Hospital
Associate Chief of the Cardiovascular Division

Program Planning Committee:
Chairman
Paul S. Jellinger, MD, FACE
Immediate Past President, American College of Endocrinology
The Center for Diabetes and Endocrine Care
University of Miami School of Medicine

Co-chairmen
Sam Lerman, MD, FACE
The Center for Diabetes and Endocrine Care
University of Miami School of Medicine

Louis Chaykin, MD
Aventura Hospital and Medical Center
Clinical Associate Professor of Medicine at Nova Southeastern University of
Medical Sciences

Educational Consultant
Catherine Waud, M.D.
Assistant Professor of Medicine
University of Massachusetts Medical School

Activity Director: Alan Goodstat, LCSW

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 7.25 Prescribed credit hours by the American Academy of Family Physicians.

This program was supported through educational grants from the following companies: Abbot Laboratories, Amgen, Amylin, Lilly, Novartis, Novo Nordisk, Pfizer, Procter & Gamble, Solvay, Takeda.